Correlation Engine 2.0
Clear Search sequence regions


Mantle cell lymphoma (MCL) is an aggressive neoplasm with a short survival. Cases with leukaemic MCL and splenomegaly without adenopathies (non-nodal MCL) may have a more indolent course. To gain insights into the biological features underlying this presentation, we investigated the gene expression profile (GEP) and the IGHV mutational status in a cohort of leukaemic MCL cases. Comparison of MCL with other lymphoproliferative disorders (i.e. splenic marginal zone lymphoma, follicular lymphoma, chronic lymphocytic leukaemia) revealed a MCL signature enriched for the following gene categories: mitochondrion, oxidoreductase activity, response to stress, to DNA damage and TP53-pathway. Furthermore, GEP analysis revealed that non-nodal MCL cases were characterized by the down-modulation of the following gene categories: cell projection, actin cytoskeleton organization, cell adhesion (ITGAE, CELSR1, PCDH9) and tumour invasion/progression (PGF, ST14, ETS1, OCIAD1, EZR). Many down-modulated genes were related to the TP53-pathway and to DNA damage response. IGHV status proved unmutated in all nodal and mutated in all non-nodal MCL. Non-nodal leukaemic MCLs display a peculiar clinical presentation, with distinctive biological features, such as mutated IGHV and a transcriptional profile lacking tumour invasion properties, that might contribute to the absence of nodal involvement and to the less aggressive clinical course. © 2011 Blackwell Publishing Ltd.

Citation

Ilaria Del Giudice, Monica Messina, Sabina Chiaretti, Simona Santangelo, Simona Tavolaro, Maria Stefania De Propris, Mauro Nanni, Edoardo Pescarmona, Francesca Mancini, Alessandro Pulsoni, Maurizio Martelli, Alice Di Rocco, Erica Finolezzi, Francesca Paoloni, Francesca R Mauro, Antonio Cuneo, Anna Guarini, Robin Foà. Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes. British journal of haematology. 2012 Mar;156(5):601-11

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 22150124

View Full Text